Filing Manager
BAYER HEALTHCARE LLC
Reporting Manager
Bayer HealthCare LLC
Symbol
SNTI
Shares outstanding
30,729,605 shares
Disclosed Ownership
6,142,848 shares
Ownership
20%
Form type
SCHEDULE 13D
Filing time
17 Mar 2025, 18:35:12 UTC
Date of event
10 Mar 2025

Key filing fact

BAYER HEALTHCARE LLC disclosed 20% ownership in Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI) on 10 Mar 2025.

Key facts

  • BAYER HEALTHCARE LLC filed SCHEDULE 13D for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI).
  • Disclosed ownership: 20%.
  • Date of event: 10 Mar 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Mar 2025, 18:35.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bayer HealthCare LLC 20% 6,142,848 0 6,142,848 /s/ Priyal Patel Priyal Patel, Treasurer 0001231517
Bayer US Holding LLC 20% 6,142,848 0 6,142,848 /s/ Priyal Patel Priyal Patel, Treasurer 0001965754
Sebastian Guth 20% 6,142,848 0 6,142,848 /s/ Sebastian Guth Sebastian Guth
Gurumurthy Ramamurthy 20% 6,142,848 0 6,142,848 /s/ Gurumurthy Ramamurthy Gurumurthy Ramamurthy
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .